---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-062982"
form_type: "8-K"
ticker: "SRTS"
cik: "0001494891"
company_name: "Sensus Healthcare, Inc."
filed_at: "2023-08-03T23:59:59+00:00"
generated_at: "2026-06-12T07:55:47.022500+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Sensus Healthcare Q2 revenue $4.5M (-63% YoY), net loss $0.4M vs $3.5M profit last year

## Summary
- Revenue $4.5M, down 63% YoY from $12.1M; net loss $0.4M ($0.02/sh) vs net income $3.5M ($0.21/sh) in Q2 2022.
- Shipped 13 SRT systems (down from 33 YoY) but up from 10 in Q1; total installed base 708 systems worldwide.
- Cash $20.1M, no debt; gross margin 57.9% vs 68.3% a year ago on lower volume and higher vendor costs.
- Guidance: expects to ship at least 60 SRT systems in 2023 and return to profitability in H2 2023.
- New UK/Ireland distribution with MIS Healthcare; first sale in Ireland; international expansion progressing.

## SEC filing metadata
- accession: 0001213900-23-062982
- form_type: 8-K
- ticker: SRTS
- cik: 0001494891
- company_name: Sensus Healthcare, Inc.
- filed_at: 2023-08-03T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1494891/000121390023062982/0001213900-23-062982-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1494891/000121390023062982/ea182698-8k_sensus.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-062982
- JSON: https://secwatch.observer/filing/0001213900-23-062982.json
- Plain text: https://secwatch.observer/filing/0001213900-23-062982.txt

## Key facts
- Earnings Releases
  Sensus Healthcare, Inc. reported the three and six months ended June 30, 2023 results: revenue $4.5 million, net income $0.4 million, or $0.02 per share (net loss), EPS $0.02 per share. Guidance reaffirmed.
  - Period: the three and six months ended June 30, 2023
  - Revenue: $4.5 million
  - Net income: $0.4 million, or $0.02 per share (net loss)
  - EPS: $0.02 per share
  - Guidance: reaffirmed
  - Result: reported results
  source text: financial results for the three and six months ended June 30, 2023. Highlights from the second quarter of 2023 and recent weeks include the following: ● Achieved revenues of $4.5 million, an increase of 33% from $3.4 million for the first quarter of 2023 and a decrease from $12.1 million in the prior-year quarter reflecting lower SRT unit sales ● Shipped 13 SRT
  evidence_url: https://www.sec.gov/Archives/edgar/data/1494891/000121390023062982/0001213900-23-062982-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.